|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1984-11-19
|
|
pubmed:abstractText |
To avoid nephrotoxicity and hepatotoxicity the CsA-PL should be kept at less than 500 ng/mL during the first month after transplantation and less than 200 ng/mL after four months. After ten months most patients in this study had a CsA-PL of less than 150 ng/mL and many had levels of less than 50 ng/mL with an apparently good immunosuppressive effect. Rejections showed no correlation with high or low CsA-PL. Continuous monitoring of CsA-PL is recommended for the management of renal allograft recipients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0041-1345
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1208-11
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:6385380-Adolescent,
pubmed-meshheading:6385380-Adult,
pubmed-meshheading:6385380-Aged,
pubmed-meshheading:6385380-Child,
pubmed-meshheading:6385380-Child, Preschool,
pubmed-meshheading:6385380-Cyclosporins,
pubmed-meshheading:6385380-Drug-Induced Liver Injury,
pubmed-meshheading:6385380-Female,
pubmed-meshheading:6385380-Graft Rejection,
pubmed-meshheading:6385380-Humans,
pubmed-meshheading:6385380-Kidney Diseases,
pubmed-meshheading:6385380-Kidney Transplantation,
pubmed-meshheading:6385380-Male,
pubmed-meshheading:6385380-Middle Aged,
pubmed-meshheading:6385380-Time Factors
|
|
pubmed:year |
1984
|
|
pubmed:articleTitle |
Optimal cyclosporine plasma levels decline with time of therapy.
|
|
pubmed:publicationType |
Journal Article
|
